NCT04748744View on ClinicalTrials.gov

Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

November 6, 2019

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Colorectal DisordersColorectal Neoplasms
Interventions
COMBINATION_PRODUCT

Butyrylcholinesterase

Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases

Trial Locations (1)

26223

Francesk Mulita, Pátrai

All Listed Sponsors
lead

University Hospital of Patras

OTHER

NCT04748744 - Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases | Biotech Hunter | Biotech Hunter